# Telomir Pharmaceuticals, Inc.: filings

TELO · Nasdaq · CIK 1971532 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/telo.md) · [Financials](/companies/telo/financials.md) · [Filings](/companies/telo/filings.md) · [Insiders](/companies/telo/insiders.md)

## Reports and events: 79 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 63, 4 17, 3 16, 10-Q 8, CORRESP 6, UPLOAD 5, 10-K 3, PRER14A 3, S-1/A 3, DEFA14A 2, EFFECT 2, SCHEDULE 13G/A 2, 424B1 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, D 1, DEF 14A 1, DEFM14A 1, DRS 1, DRS/A 1, DRSLTR 1, PREM14A 1, S-1 1, S-3 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 08:00 ET | [8-K](/filings/0001493152-26-045860.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045860 |
| 2026-09-17 | 08:30 ET | [8-K](/filings/0001493152-26-043053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043053 |
| 2026-09-16 | 16:30 ET | [8-K](/filings/0001493152-26-042926.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-042926 |
| 2026-09-14 | 08:00 ET | [8-K](/filings/0001493152-26-042483.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042483 |
| 2026-08-13 | 17:10 ET | [10-Q](/filings/0001493152-26-037854.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037854 |
| 2026-08-10 | 08:00 ET | [8-K](/filings/0001493152-26-036742.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036742 |
| 2026-07-28 | 17:00 ET | [DEF 14A](/filings/0001493152-26-035026.md) | Proxy statement, period 2026-07-28 | 0001493152-26-035026 |
| 2026-06-15 | 08:00 ET | [8-K](/filings/0001493152-26-028614.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028614 |
| 2026-06-08 | 17:00 ET | [8-K](/filings/0001493152-26-027752.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-027752 |
| 2026-05-20 | 08:00 ET | [8-K](/filings/0001493152-26-024517.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-024517 |
| 2026-05-14 | 15:09 ET | [10-Q](/filings/0001493152-26-023010.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023010 |
| 2026-04-30 | 08:15 ET | [8-K](/filings/0001493152-26-019773.md) | 8.01 Other events | 0001493152-26-019773 |
| 2026-04-24 | 09:00 ET | [8-K](/filings/0001493152-26-018867.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-018867 |
| 2026-03-31 | 09:15 ET | [8-K](/filings/0001493152-26-013872.md) | 8.01 Other events | 0001493152-26-013872 |
| 2026-03-31 | 07:00 ET | [8-K](/filings/0001493152-26-013785.md) | 8.01 Other events | 0001493152-26-013785 |
| 2026-03-27 | 17:00 ET | [8-K](/filings/0001493152-26-013240.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-013240 |
| 2026-03-17 | 17:28 ET | [10-K](/filings/0001493152-26-010625.md) | Annual report, period 2025-12-31 | 0001493152-26-010625 |
| 2026-02-17 | 08:00 ET | [8-K](/filings/0001493152-26-006937.md) | 8.01 Other events | 0001493152-26-006937 |
| 2026-02-05 | 07:30 ET | [8-K](/filings/0001493152-26-005199.md) | 8.01 Other events | 0001493152-26-005199 |
| 2026-01-12 | 19:50 ET | [8-K](/filings/0001493152-26-001170.md) | 3.01 Delisting notice | 0001493152-26-001170 |
| 2026-01-05 | 08:00 ET | [8-K](/filings/0001493152-26-000267.md) | 8.01 Other events | 0001493152-26-000267 |
| 2025-12-22 | 20:00 ET | [8-K](/filings/0001493152-25-028620.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-028620 |
| 2025-12-17 | 16:01 ET | [8-K](/filings/0001493152-25-028126.md) | 8.01 Other events | 0001493152-25-028126 |
| 2025-11-24 | 16:01 ET | [8-K](/filings/0001493152-25-024818.md) | 8.01 Other events | 0001493152-25-024818 |
| 2025-11-20 | 17:15 ET | [8-K](/filings/0001493152-25-024491.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-024491 |
| 2025-11-20 | 16:01 ET | [8-K](/filings/0001493152-25-024450.md) | 8.01 Other events | 0001493152-25-024450 |
| 2025-11-12 | 07:00 ET | [8-K](/filings/0001493152-25-021712.md) | 8.01 Other events | 0001493152-25-021712 |
| 2025-11-10 | 16:01 ET | [10-Q](/filings/0001493152-25-021496.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021496 |
| 2025-10-22 | 16:01 ET | [8-K](/filings/0001493152-25-018907.md) | 8.01 Other events | 0001493152-25-018907 |
| 2025-10-20 | 16:01 ET | [8-K](/filings/0001493152-25-018634.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018634 |
| 2025-10-14 | 07:30 ET | [8-K](/filings/0001493152-25-017916.md) | 8.01 Other events | 0001493152-25-017916 |
| 2025-10-08 | 16:01 ET | [8-K](/filings/0001493152-25-017422.md) | 8.01 Other events | 0001493152-25-017422 |
| 2025-10-06 | 16:01 ET | [8-K](/filings/0001493152-25-017072.md) | 8.01 Other events | 0001493152-25-017072 |
| 2025-09-18 | 07:30 ET | [8-K](/filings/0001493152-25-013970.md) | 8.01 Other events | 0001493152-25-013970 |
| 2025-09-09 | 07:30 ET | [8-K](/filings/0001641172-25-026931.md) | 8.01 Other events | 0001641172-25-026931 |
| 2025-09-04 | 10:13 ET | [8-K](/filings/0001641172-25-026527.md) | 8.01 Other events | 0001641172-25-026527 |
| 2025-08-27 | 16:01 ET | [8-K](/filings/0001641172-25-025688.md) | 8.01 Other events | 0001641172-25-025688 |
| 2025-08-14 | 16:02 ET | [10-Q](/filings/0001641172-25-023970.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023970 |
| 2025-08-07 | 07:30 ET | [8-K](/filings/0001641172-25-022506.md) | 8.01 Other events | 0001641172-25-022506 |
| 2025-07-23 | 16:01 ET | [8-K](/filings/0001641172-25-020687.md) | 8.01 Other events | 0001641172-25-020687 |
| 2025-07-22 | 16:01 ET | [8-K](/filings/0001641172-25-020563.md) | 8.01 Other events | 0001641172-25-020563 |
| 2025-07-17 | 16:01 ET | [8-K](/filings/0001641172-25-020042.md) | 8.01 Other events | 0001641172-25-020042 |
| 2025-06-18 | 09:15 ET | [8-K](/filings/0001641172-25-015522.md) | 8.01 Other events | 0001641172-25-015522 |
| 2025-06-11 | 09:30 ET | [8-K](/filings/0001641172-25-014648.md) | 8.01 Other events | 0001641172-25-014648 |
| 2025-06-05 | 08:00 ET | [8-K](/filings/0001641172-25-013711.md) | 8.01 Other events | 0001641172-25-013711 |
| 2025-06-02 | 08:00 ET | [8-K](/filings/0001641172-25-013196.md) | 8.01 Other events | 0001641172-25-013196 |
| 2025-05-29 | 08:00 ET | [8-K](/filings/0001641172-25-012785.md) | 8.01 Other events | 0001641172-25-012785 |
| 2025-05-21 | 17:25 ET | [8-K](/filings/0001641172-25-011938.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-011938 |
| 2025-05-21 | 08:45 ET | [8-K](/filings/0001641172-25-011868.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001641172-25-011868 |
| 2025-05-15 | 07:45 ET | [8-K](/filings/0001641172-25-010518.md) | 8.01 Other events | 0001641172-25-010518 |

Page 1 of 2. [Older](/companies/telo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:31 ET. No prices; not investment advice.